- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01616147
LIFT: Lifestyle Interventions For Two (LIFT)
LIFT: Lifestyle Interventions For Two (Member of the LIFE Moms Consortium)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Overall body weight and weight gain during pregnancy have gone up among all women in the United States. Higher body weight of the mother at the time of the baby's conception and a greater weight gain during pregnancy are both associated with more fat in the infant and later overweight in children. Obesity in children has become a great public health problem. This study will use the new Institute of Medicine Guidelines for weight gain during pregnancy. These Guidelines are based on observations showing that women whose weight gain was within the recommended Guidelines had healthier pregnancies and better pregnancy outcomes than those who did not follow the Guidelines. It is important for researchers to understand whether a lifestyle intervention like LIFT can help women have healthier pregnancies and healthier babies. If the researchers find that a lifestyle intervention positively impacts the mothers and their babies, then the researchers can help other pregnant women have healthier pregnancies and babies as well.
This Study, The Lifestyle Intervention For Two (LIFT) Study, is part of the LIFE Moms consortium, a national project involving seven sites across the US. The purpose of the LIFE Moms consortium is to study different ways in which women who are overweight or obese can manage their body weight during pregnancy, and how this may affect them and their baby's health at birth and through the first year. As part of the LIFE Moms consortium, The LIFT Study will look how controlled weight gain during pregnancy will impact the health of the mother and her child. Researchers at Columbia University are investigating the effect of an intensive lifestyle intervention (i.e. diet and physical activity counseling). The researchers hope to positively impact not only body weight gain during pregnancy, but also positively impact infant body fatness and mother's weight loss after pregnancy. The LIFE Moms researchers are looking at whether too much weight gain in the mother will result in a leaner baby, and less retention of fat by the mother following pregnancy.
This study is a randomized controlled trial to study the effect, in a cohort of racially and ethnically diverse group of overweight and obese pregnant women, of an Intensive Lifestyle Intervention (ILI) compared to Usual Care (UC) on gestational weight gain (GWG), infant fatness, and mothers' post-delivery weight retention. Women in the ILI arm will receive intensive counseling during pregnancy and group counseling after delivery regarding behavior, nutrition, and physical activity change. Visits to counselors will occur semi-monthly and additional telephone and internet contacts will occur. The mothers' will be assessed at 14 and 36 weeks of pregnancy and at 14 weeks (range 13-15) and 52 (range 48-56) weeks post-delivery. The measurements will be anthropometry, whole body MRI, EchoMRI, and whole body plethysmography (BodPod). The infants' measurements will be anthropometry, whole body MRI, EchoMRI, and whole body plethysmography (PeaPod) for fatness 14 weeks (range 14-15) weeks and 52 (range 48-56) weeks. Mothers and children will have cardio-metabolic risk factors measured in plasma. Data will be collected regarding mothers' dietary intake and physical activity (questionnaires and accelerometry) to assist in counseling. Other data to be collected include questionnaires on quality of life, socio-economic status. Each mother will be followed during pregnancy and for a year post delivery. Each infant will be followed for a year after birth. The researchers have the ability to continue to follow these participants if further funding is forthcoming, as they are all local to the hospital's catchment area and to own physicians.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Singleton viable pregnancy
- Gestational age between 9,0 and 15,6
- Body Mass Index of 25 and above
- Age 18 and over
- Ability to contact
Exclusion Criteria:
- Less than 18 years old
- Diagnosis of Diabetes or Hemoglobin A1c (HbA1c)> or = 6.5%
- Known fetal anomaly
- Planned termination of pregnancy
- History of 3 more more consecutive first trimester miscarriages
- Current eating disorder
- Actively suicidal
- Prior or planned bariatric surgery
- Current use of metformin, systemic steroids, antipsychotic agents, anti-seizure medications, mood stabilizers, attention deficit hyperactivity disorder medications
- Continued use of weight loss medication
- Contraindications to aerobic exercise in pregnancy
- Participation in another interventional study that influences weight control
- Enrollment in this trial in a previous pregnancy
- Intention of the participant or of the care provider for the delivery to be outside the Lifestyle Interventions For Expectant (LIFE) Moms consortium hospital
- Participant's unwillingness or inability to commit to a 1 year follow-up of herself or her child, including planning to move away
- Smoking
- History of Drug and/or Alcohol Addiction
- Chronic health problems that prohibit regular exercise or known to influence body composition
- Other chronic disease as determined by investigators
- Claustrophobia (only for participants who elect to have MRI)
- Implanted metal objects that render MRI unsafe (only for participants who elect to have MRI)
- Lack of support from primary health care provider or family members
- Another member of the household is a study participant or staff member
- Any other medical, psychiatric, social or behavioral factor that in the judgement of the Principal Investigator (PI) may interfere with study participation or ability to follow the intervention protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intensive Lifestyle Intervention (ILI)
Women in the ILI arm will receive intensive counseling during pregnancy and group counseling after delivery regarding behavior, nutrition, and physical activity change.
Visits to counselors will occur twice monthly with additional weekly telephone and internet contacts.
|
Women in the ILI arm will receive intensive counseling during pregnancy and group counseling after delivery regarding behavior, nutrition, and physical activity change.
Visits to counselors will occur twice monthly with additional weekly telephone and internet contacts.
|
|
Active Comparator: Usual Care
Women in the usual care group will be offered group support classes approximately every 2 months during pregnancy and 3 months after pregnancy.
|
Women in the usual care group will be offered group support classes approximately every 2 months during pregnancy and 3 months after pregnancy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infant Percent Fat at Birth
Time Frame: Within 24 hours of birth
|
Infant % fat at birth as a continuous variable.
This will be ascertained from PeaPod within 24 hours after birth.
|
Within 24 hours of birth
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mother fat mass gain 35 Weeks
Time Frame: 35,0-35,6 weeks of pregnancy
|
Fat mass gain of mother at 35,0-35,6 weeks of pregnancy as a continuous variable.
|
35,0-35,6 weeks of pregnancy
|
|
Mother fat mass gain one year postpartum
Time Frame: 48-56 weeks postpartum
|
Mother's fat mass at 52 (range 48-56) weeks postpartum
|
48-56 weeks postpartum
|
|
Mother's weight one-year postpartum
Time Frame: 48-56 weeks postpartum
|
Weight of mother at 52 (range 48-56) weeks
|
48-56 weeks postpartum
|
|
Infant % fat 14 weeks
Time Frame: 13-15 weeks
|
Infant %fat at 14 (range 13-15) weeks.
This will be ascertained from PeaPod.
|
13-15 weeks
|
|
Infant % fat 52 weeks
Time Frame: 48-52 weeks
|
Infant %fat 52 (range 48-56) weeks.
|
48-52 weeks
|
|
Infant Weight 14 weeks
Time Frame: 13-15 weeks
|
Infant weight at 14 (range 13-15) weeks.
|
13-15 weeks
|
|
Infant weight 52 weeks
Time Frame: 48-56 weeks
|
Infant weight at 52 (range 48-56) weeks.
|
48-56 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dympna Gallagher, EdD, Columbia University
Publications and helpful links
General Publications
- Redman LM, Drews KL, Klein S, Horn LV, Wing RR, Pi-Sunyer X, Evans M, Joshipura K, Arteaga SS, Cahill AG, Clifton RG, Couch KA, Franks PW, Gallagher D, Haire-Joshu D, Martin CK, Peaceman AM, Phelan S, Thom EA, Yanovski SZ, Knowler WC; LIFE-Moms Research Group. Attenuated early pregnancy weight gain by prenatal lifestyle interventions does not prevent gestational diabetes in the LIFE-Moms consortium. Diabetes Res Clin Pract. 2021 Jan;171:108549. doi: 10.1016/j.diabres.2020.108549. Epub 2020 Nov 22.
- Peaceman AM, Clifton RG, Phelan S, Gallagher D, Evans M, Redman LM, Knowler WC, Joshipura K, Haire-Joshu D, Yanovski SZ, Couch KA, Drews KL, Franks PW, Klein S, Martin CK, Pi-Sunyer X, Thom EA, Van Horn L, Wing RR, Cahill AG; LIFE-Moms Research Group. Lifestyle Interventions Limit Gestational Weight Gain in Women with Overweight or Obesity: LIFE-Moms Prospective Meta-Analysis. Obesity (Silver Spring). 2018 Sep;26(9):1396-1404. doi: 10.1002/oby.22250. Epub 2018 Sep 6.
- Clifton RG, Evans M, Cahill AG, Franks PW, Gallagher D, Phelan S, Pomeroy J, Redman LM, Van Horn L; LIFE-Moms Research Group. Design of lifestyle intervention trials to prevent excessive gestational weight gain in women with overweight or obesity. Obesity (Silver Spring). 2016 Feb;24(2):305-13. doi: 10.1002/oby.21330. Epub 2015 Dec 26.
- Whyte K, Contento I, Wolf R, Guerra L, Martinez E, Pi-Sunyer X, Gallagher D. A secondary analysis of maternal ultra-processed food intake in women with overweight or obesity and associations with gestational weight gain and neonatal body composition outcomes. J Mother Child. 2022 Mar 23;25(4):244-259. doi: 10.34763/jmotherandchild.20212504.d-21-00025. eCollection 2021 Dec 1.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAO0651
- 1U01DK094463 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Carmen Lucas AbellánUniversidad Católica San Antonio de MurciaCompletedOverweight/Obesity | Overweight or Obese | Overweight or Obese Adults | Obesity and Overweight | Obese SubjectsSpain
-
Empros Pharma ABNot yet recruitingOverweight or Obese | Obesity and Overweight
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Children's Hospital Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight, Childhood | Overweight, InfantFrance
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Medialis Ltd.RecruitingObesity & Overweight | Overweight (BMI > 25)United Kingdom
-
Federal University of Health Science of Porto AlegreCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Active, not recruitingObesity & Overweight | Overweight (BMI > 25)Brazil
Clinical Trials on Intensive Lifestyle Intervention (ILI)
-
University of TennesseeNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Type 2 Diabetes | PrediabetesUnited States
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedDiabetes Mellitus, Type 2
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedDiabetes Mellitus Type 2
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Sheba Medical CenterD-Cure, Israel; Chief Scientist, The Israel Ministry of ScienceCompleted
-
The University of Hong KongSuspendedInsomnia | PreDiabetes | Sleep DeprivationHong Kong
-
Istituti Clinici Scientifici Maugeri SpAActive, not recruiting
-
Pennington Biomedical Research CenterUniversity of Alabama at Birmingham; National Institute on Minority Health... and other collaboratorsActive, not recruitingObesity | Diabetes Mellitus, Type 2 | PreDiabetesUnited States
-
Norwegian School of Sport SciencesHjelp24Completed
-
Wake Forest University Health SciencesNational Center for Advancing Translational Sciences (NCATS); W.G. Bill Hefner...WithdrawnMigraine | Migraine Disorders | Migraine Without Aura | Migraine With Aura